A Walsh-trained physician considers: Zinc/copper ratio Neurotransmitter tendencies Sensitivity to folate Oxidative stress load Inflammatory markers Medication interactions Genetic tendencies without being limited by them A proper methylation test provides the biochemical map
For CagriSema, studies have found that a weekly combination of cagrilintide and semaglutide leads to significant weight loss
10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective
Several GLP-1RAs have been approved for the treatment of obesity
Consult with your provider to consider all aspects of any treatment before starting.**
These bacterial shifts dont happen overnight, though